TerminatedNCT00805493
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolarity
Medication studyAges 9–17United States
Understand this study
Who could participate?
Listed age limits: 9 years to 17 years.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNovember 2008
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 6
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 9 Years to 17 Years
- Official registry ID
- NCT00805493
- Official title
Show the full official title
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Does this study involve medication?
Yes. The study involves medication, including Riluzole.
Who can participate?
Listed age limits: 9 years to 17 years.
Is this study still recruiting?
The registry lists this study as terminated.
